Stocks and Investing Stocks and Investing
Tue, January 14, 2020
Mon, January 13, 2020

Leland Gershell Maintained (URGN) at Buy with Decreased Target to $52 on, Jan 13th, 2020


Published on 2024-10-26 20:01:53 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Maintained "UroGen Pharma Ltd." (URGN) at Buy with Decreased Target from $62 to $52 on, Jan 13th, 2020.

Leland, nor any peers, have made any analyst calls on URGN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources